by If you searched orforglipron side effects, the short answer is that the ones reported most often in the research so far are stomach-related: nausea, vomiting and constipation, with acid reflux also common in the 2024 review. They rise with higher doses, and serious side effects did not increase significantly in that review.
If you have seen news about orforglipron and heart safety, you may be wondering what it means for you. Below we separate the heart question from the side effect question and lay out the options side by side.
What are the side effects of orforglipron?
Two reviews of the clinical trials give the clearest picture so far. A 2024 meta-analysis of orforglipron trials pooled three randomized trials with 774 people, followed for up to 36 weeks. It found that gastrointestinal side effects were the main ones, that they were dose-dependent, and that nausea, vomiting, constipation and gastroesophageal reflux were the most common. Total side effects were higher on every dose than on placebo, but severe ones did not rise significantly. The authors judged the middle doses to offer the best balance of weight loss and side effects.
A 2026 review of placebo-controlled trials reported the same pattern. It described gastrointestinal side effects as common but typical of the GLP-1 class, with relative risks of 5.22 for nausea, 3.24 for vomiting and 6.80 for eructation, meaning belching.
| Side effect | What the orforglipron reviews report | Also listed for GLP-1 medicines in general |
|---|---|---|
| Nausea | Among the predominant effects in the 2024 review; relative risk 5.22 in the 2026 review | Common (Cleveland Clinic) |
| Vomiting | Among the predominant effects in the 2024 review; relative risk 3.24 in the 2026 review | Common (Cleveland Clinic) |
| Constipation | Among the predominant effects in the 2024 review | Common (Diabetes UK, Harvard Health) |
| Rare but serious problems | Severe adverse events did not rise significantly in the 2024 review | Pancreatitis, acute kidney injury, medullary thyroid cancer and worsening diabetes-related eye disease are listed as rare (Cleveland Clinic) |
Some people should be more careful. Harvard Health says people with gastroparesis or uncontrolled inflammatory bowel disease should not take GLP-1 medicines, and that they are not considered safe during pregnancy or breastfeeding. Diabetes UK says a past bout of pancreatitis may make a GLP-1 unsuitable. Persistent nausea or vomiting can lead to dehydration, so report it to your care team early.
Diabetes UK's GLP-1 guide also notes that the European Medicines Agency and the US Food and Drug Administration investigated reports of suicidal thoughts and found no evidence that these medicines cause them. They continue to monitor the issue, so report any sudden change in mood to your care team.
Does the heart news mean orforglipron is safe for my heart?
The 2026 review pooled changes in cholesterol, blood pressure and blood sugar, and it reports those as risk factors. It does not report heart attacks or strokes, so on its own it does not answer the heart-event question.
Is orforglipron a new weight loss pill, and is it available?
Orforglipron is a once-daily oral GLP-1 receptor agonist. Both reviews describe it as a non-peptide, small-molecule drug, which is one reason it is a different product from the injectable GLP-1 medicines. The 2026 review pooled weight loss of 6.08% against placebo, and up to 9.31% at higher doses. The 2024 review reported roughly 5.5% more weight loss than placebo at one of the doses it studied.
A ClinicalTrials.gov registration (NCT06692348) describes a phase 1 study comparing a single capsule with multiple capsules of orforglipron in healthy participants, with 86 planned or enrolled. As of November 2026 the registry marks the study as completed. A registration describes a study; it is not a result.
Whether orforglipron is approved where you live, and under which brand name, is the first thing to settle. Your pharmacist can confirm approval status in your country.
What is the safest weight loss medication?
No single medicine is the safest for everyone. Your blood sugar, heart and kidney health, pancreas history, pregnancy plans and other medicines all change the answer, so settle this with your clinician. For orforglipron, the reviews point to stomach effects that rise with dose. Our guide to the safest weight-loss drug walks through the questions to bring to that conversation.
What is the cheapest weight loss medication?
The cheapest route depends on your insurance, your prescription and the program you use. The National Academy of Medicine's GLP-1 overview, last updated January 20, 2026, says most injectable GLP-1 options can cost up to $500 a month through manufacturer direct-to-patient programs with a valid prescription. It adds that most commercial plans cover GLP-1s for diabetes but fewer cover them for weight management, and that Medicare covers them for diabetes, sleep apnea, cardiovascular risk reduction and MASH. It also says that in November 2025 the administration announced a demonstration project to extend coverage to people with obesity, starting later in 2026. As of November 2026, check your plan directly for what applies to you.
No orforglipron price appears on this page, so check today's price with the company or your pharmacist, since prices change.
What are the best non-prescription weight loss pills?
Prescription GLP-1 medicines are the ones with trials discussed in this article. Over-the-counter pills are a separate category, so treat each one on its own label. Read the ingredient list and amounts, look up the research on each ingredient, and ask the seller for the studies behind its claims before you spend money.
A common example is the Gentle Patches sales page, which sells a skin patch rather than a pill. The page says each patch delivers berberine, cinnamon extract and green tea extract through the skin, and that berberine ‘naturally triggers your body to produce more GLP-1.' That is the seller's claim. Its disclaimer says its statements have not been evaluated by the Food and Drug Administration. The page advertises a 30-day money-back guarantee and lists a 30-day supply at $14.99, against a $49.99 retail price per pack (prices as of October 5, 2026; check the checkout for today's). Before you order anything like this, get the refund terms from the order page in writing.
Could I just change my routine instead?
The basics still matter, and a routine is a reasonable base. Healthline's weight-loss plateau reasons notes that people who track their food in a diary tend to lose more weight, though food tracking can aggravate symptoms for people with eating disorders. Protein helps you feel fuller for longer, and adults are generally advised to get 7 to 8 hours of sleep a night. A medicine is an add-on decision to make with a clinician, not a replacement for the basics. For a fuller plan, see our guide to the most effective way to lose weight.
How do the prescription options compare?
| Option | What the sources say | Cost | Who it may suit and limits |
|---|---|---|---|
| Orforglipron (oral, once daily) | In trials; the 2026 review pooled about 6.08% weight loss, up to 9.31% at higher doses | Check with the company or pharmacy for today's price | Depends on approval and your clinician; stomach side effects are the most common |
| Semaglutide injection (Wegovy) | FDA-approved for weight loss (Harvard Health) | Injectables can cost up to $500 a month (National Academy of Medicine) | Once-weekly injection (Cleveland Clinic); nausea and related stomach effects are common |
| Semaglutide tablet (Rybelsus) | Daily tablet listed for type 2 diabetes (Diabetes UK) | Check with the pharmacy for today's price | Diabetes UK notes rare reports of sudden vision loss (NAION) with semaglutide; seek urgent advice if it happens |
| Tirzepatide (Zepbound, Mounjaro) | Zepbound FDA-approved for weight loss; Mounjaro used for type 2 diabetes (Harvard Health, Cleveland Clinic) | Check with the company or pharmacy for today's price | Once-weekly injection (Cleveland Clinic) |
| Liraglutide (Saxenda, high dose) | FDA-approved for weight loss (Harvard Health) | Check with the pharmacy for today's price | Once-daily injection (Cleveland Clinic) |
| Compounded GLP-1 versions | FDA has issued warnings about harmful side effects (Harvard Health); not assessed for safety, effectiveness or quality (National Academy of Medicine) | Less expensive than branded versions (National Academy of Medicine) | May be stored improperly or be fraudulent, per the National Academy of Medicine; discuss any compounded product with your clinician first |
| Lifestyle routine | Food tracking, protein, sleep and water are linked to weight loss in the research Healthline summarizes | No product cost | Food tracking can aggravate symptoms in people with eating disorders |
If you are also weighing older prescription pills like phentermine, our phentermine for weight loss guide covers its side effects, cost and questions to ask.
What should I ask before I decide?
- Is orforglipron approved where you live, and under which brand name?
- Which side effects are most likely, and what should I do if nausea or vomiting keeps going?
- Do my pancreas, gallbladder, kidney, liver, eye or thyroid history, my pregnancy plans or my current medicines change my options?
- What will I pay after insurance, and what do my plan's rules say?
- What outcome did the trial in the heart headline actually measure?
Get urgent care for severe stomach pain that spreads to your back, especially with vomiting, fever or yellowing of the eyes or skin, and for sudden vision loss in one or both eyes. Diabetes UK advises urgent medical help for both.
Pick one question from the list and take it to your next appointment, along with the news link and the product label if you have one. That one step turns the headline into a decision you can make.
By the New Life Wellness Guide Editorial Team